Login
From:
iData Research
(Uncensored)
subscribe
Ozempic FDA-Approved to Lower Kidney Disease Risk in Diabetic Patients - iData Research
https://idataresearch.com/ozempic-fda-approved-to-lower-kidney-disease-risk-in-diabetic-patients/
links
backlinks
US FDA approved Novo Nordisk to use their GLP-1 drug, Ozempic, to reduce the risk of kidney failure and kidney disease progression.
Roast topics
Find topics
Find it!